secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2026-06-09T23:04:13+00:00
Accession:  0001477932-26-003740
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx prices $4.6M public offering of common stock and warrants
--------------------------------------------------------------------

- Offered 2,960,000 shares at $1.55 each plus half-warrant; gross proceeds ~$4.6M.
- Net proceeds ~$4.1M after fees; additional $2.3M possible if warrants fully exercised.
- Use of proceeds: R&D, clinical studies, commercialization, working capital, repaying secured convertible notes.
- Maxim Group LLC acted as sole placement agent; offering closed June 9, 2026.
- Warrants exercisable at $1.55 per share immediately, expire in 5 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793226003740/0001477932-26-003740-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793226003740/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-003740

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer